$CORT

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (3d)
Win rate (3d)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$CORTSEC Form 4bearish
Sold 10,000 @ $116.26 avg · $1,162,572 · 2026-08-17

Form 4: Robb Gary Charles sold CORT

Robb Gary Charles (Chief Business Officer at CORCEPT THERAPEUTICS INC) reported an open-market sale of 10,000 shares of CORT at an average $116.26, roughly $1,162,572, in a Form 4 filed 2026-08-18.

View filing on SEC.gov →

End of results.